Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 6Phase 3 5Phase 2/3 3Phase NA 2Phase 1/2 2

Status

Recruiting 2

Sponsor Class

OTHER 15INDUSTRY 2NETWORK 1INDIV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 169Neoplasms 128Prostatic Neoplasms 92Lung Neoplasms 82Colorectal Neoplasms 80Pancreatic Neoplasms 38Leiomyoma 37Carcinoma, Hepatocellular 36Lymphoma, Follicular 35Carcinoma, Non-Small-Cell Lung 31Neoplasm Metastasis 27Skin Neoplasms 26Colonic Neoplasms 26Uterine Cervical Neoplasms 25Liver Neoplasms 25Multiple Myeloma 23Glioblastoma 22Head and Neck Neoplasms 21Barrett Esophagus 21Polycystic Ovary Syndrome 19Brain Neoplasms 18Urinary Bladder Neoplasms 17Polyps 16Ovarian Neoplasms 15Esophageal Neoplasms 15Stomach Neoplasms 14Squamous Cell Carcinoma of Head and Neck 14Rectal Neoplasms 14Carcinoma, Squamous Cell 14Carcinoma, Basal Cell 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Carcinoma in Situ × Clear all
NCT07092007 2025-07-29

NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer

Newish Technology (Beijing) Co., Ltd.

Phase NA Recruiting
18 enrolled
Gynecologic

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT06741150 2024-12-18

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

Newish Technology (Beijing) Co., Ltd.

Phase NA Recruiting
18 enrolled
Gynecologic

Carcinoma in Situ, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡